Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased to have reached this milestone at the end of the year. Despite a very challenging year for elective surgeries, our customers have continued to order Episealer implants when possible. We are looking forward to continued growth, supported by strong clinical evidence,” said Pål Ryfors, CEO.
Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased...
Episurf Medical achieved a milestone with the planning of the 900th surgery with the Episealer® knee implant. Close to 400 patients have had the implant for more than two years, and approximately 70 patients have passed five years since surgery. Studies have shown excellent clinical improvements and a low revision rate.
“We are pleased to have reached this milestone at the end of the year. Despite a very challenging year for elective surgeries, our customers have continued to order Episealer implants when possible. We are looking forward to continued growth, supported by strong clinical evidence,” said Pål Ryfors, CEO.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
